Open AccessRisk of Selected Cardiovascular Toxicities in Patients With Cancer Treated With MEK Inhibitors: A Comparative Systematic Review and Meta-Analysis
Author(s) -
Omar AbdelRahman,
Hesham Elhalawani,
Hoda Ahmed
Publication year - 2015
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.2015.000802
Subject(s) - medicine , selumetinib , meta analysis , trametinib , randomized controlled trial , mek inhibitor , lower risk , medline , oncology , cancer , mapk/erk pathway , kinase , confidence interval , colorectal cancer , political science , law , kras , biology , microbiology and biotechnology
We conducted a literature-based meta-analysis of the risk of cardiovascular toxicities associated with MEK inhibitors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom